L. Pauer

发表

Exposure‐Response Analyses of the Effects of Pregabalin in Patients With Fibromyalgia Using Daily Pain Scores and Patient Global Impression of Change

Kaori Ito, B. Corrigan, D. Ouellet, 2010, Journal of clinical pharmacology.

Efficacy and safety of pregabalin for painful diabetic peripheral neuropathy in a population of Chinese patients: A randomized placebo‐controlled trial

Y. Mu, D. Fan, Quanmin Li, 2018, Journal of diabetes.

Dose–response of pregabalin for diabetic peripheral neuropathy, postherpetic neuralgia, and fibromyalgia

L. Arnold, A. Clair, B. Mccarberg, 2017, Postgraduate medicine.

Association of Alterations in Gray Matter Volume With Reduced Evoked‐Pain Connectivity Following Short‐Term Administration of Pregabalin in Patients With Fibromyalgia

Richard E. Harris, V. Napadow, D. Clauw, 2016, Arthritis & rheumatology.

Time to improvement of pain and sleep quality in clinical trials of pregabalin for the treatment of fibromyalgia.

L. Arnold, A. Clair, B. Emir, 2015, Pain medicine.

Safety profile and tolerability of up to 1 year of pregabalin treatment in 3 open-label extension studies in patients with fibromyalgia.

L. Arnold, B. Emir, B. Zeiher, 2012, Clinical therapeutics.

Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: A double-blind placebo-controlled trial

J. Rosenstock, L. Lamoreaux, J. Arezzo, 2008, BMC neurology.

Pregabalin in Patients With Painful Diabetic Peripheral Neuropathy Using an NSAID for Other Pain Conditions: A Double-Blind Crossover Study

P. Raskin, B. Parsons, J. Scavone, 2016, The Clinical journal of pain.

The Pharmacokinetics of Pregabalin in Breast Milk, Plasma, and Urine of Healthy Postpartum Women

A. Płotka, J. Scavone, C. Alvey, 2016, Journal of human lactation : official journal of International Lactation Consultant Association.

Meeting the obligation to communicate clinical trial results to study volunteers

Zachary P. Hallinan, K. Getz, Marc Wilenzick, 2012, Expert review of clinical pharmacology.

Efficacy and safety of pregabalin in elderly people with generalised anxiety disorder

S. Montgomery, K. Chatamra, E. Whalen, 2008, British Journal of Psychiatry.

Phase I Study of Oral CI-994 in Combination with Carboplatin and Paclitaxel in the Treatment of Patients with Advanced Solid Tumors

J. Nemunaitis, A. Kraker, S. Olson, 2004, Cancer investigation.

An evidence-based review of pregabalin for the treatment of fibromyalgia

L. Arnold, D. Clauw, E. Choy, 2018, Current medical research and opinion.

Prior Opioid Use Does Not Impact the Response to Pregabalin in Patients With Fibromyalgia

A. Clair, C. Argoff, B. Emir, 2016, The Clinical journal of pain.

Pregabalin Improves Pain Scores in Patients with Fibromyalgia Irrespective of Comorbid Osteoarthritis.

A. Clair, C. Argoff, B. Emir, 2016, Pain medicine.

Efficacy and Safety of Pregabalin in Patients with Fibromyalgia and Comorbid Depression Taking Concurrent Antidepressant Medication: A Randomized, Placebo-controlled Study

L. Arnold, A. Clair, P. Sarzi-Puttini, 2015, The Journal of Rheumatology.

Once daily controlled-release pregabalin in the treatment of patients with fibromyalgia: a phase III, double-blind, randomized withdrawal, placebo-controlled study

L. Arnold, A. Clair, P. Arsenault, 2014, Current medical research and opinion.

Pregabalin in Patients With Inadequately Treated Painful Diabetic Peripheral Neuropathy: A Randomized Withdrawal Trial

P. Raskin, L. Pauer, C. Toth, 2013, The Clinical journal of pain.

Long-term Maintenance of Response Across Multiple Fibromyalgia Symptom Domains in a Randomized Withdrawal Study of Pregabalin

B. Zeiher, T. K. Murphy, L. Pauer, 2012, The Clinical journal of pain.

An International, Randomized, Double-blind, Placebo-controlled, Phase III Trial of Pregabalin Monotherapy in Treatment of Patients with Fibromyalgia

P. Arsenault, A. Winkelmann, B. Zeiher, 2011, The Journal of Rheumatology.

Safety and efficacy of pregabalin in adolescents with fibromyalgia: a randomized, double-blind, placebo-controlled trial and a 6-month open-label extension study

L. Arnold, A. Clair, J. Scavone, 2016, Pediatric Rheumatology.

Efficacy and Safety of Pregabalin in the Treatment of Patients With Painful Diabetic Peripheral Neuropathy and Pain on Walking

B. Parsons, B. Stacey, Chunming Li, 2015, The Clinical journal of pain.

Normalizing fibromyalgia as a chronic illness

D. Clauw, Y. D'arcy, L. Pauer, 2018, Postgraduate medicine.

Pregabalin for the treatment of generalized anxiety disorder (GAD): Efficacy and safety in elderly patients

S. Montgomery, K. Chatamra, F. Mandel, 2007, European psychiatry.

Effect of Baseline Characteristics on the Pain Response to Pregabalin in Fibromyalgia Patients with Comorbid Depression

S. Silverman, A. Clair, M. Backonja, 2018, Pain medicine.

Long-term safety and tolerability of pregabalin treatment in three open-label extension studies in patients with fibromyalgia

B. Herman, B. Zeiher, L. Pauer, 2009 .

Prediction of Differential Pharmacologic Response in Chronic Pain Using Functional Neuroimaging Biomarkers and a Support Vector Machine Algorithm: An Exploratory Study

Richard E. Harris, S. Peltier, S. Harte, 2021, Arthritis & rheumatology.

ABSTRACT Background: Chronic pain remains a significant challenge for modern health care as its pathologic mechanisms are largely unknown and preclinical animal models suffer from limitations in assessing this complex subjective experience. However, human brain neuroimaging techniques enable the ass

Tobias Schmidt-Wilcke, Vitaly Napadow, Pia C. Sundgren, 2013 .

Disambiguating pharmacological mechanisms from placebo in neuropathic pain using functional neuroimaging

I. Tracey, W. Vennart, E. Duff, 2017, British journal of anaesthesia.

Efficacy and Safety of Pregabalin for Fibromyalgia in a Population of Chinese Subjects

Huji Xu, Yang Li, Fengchun Zhang, 2021, Journal of pain research.

Response to "Treating patients rather than their functional neuroimages" (Br J Anaesth 2018; 121: 969-71).

E. Duff, I. Tracey, W. Vennart, 2019, British journal of anaesthesia.

Response to "Treating patients rather than their functional neuroimages" (Br J Anaesth 2018; 121: 969-71).

E. Duff, I. Tracey, W. Vennart, 2019, British journal of anaesthesia.

Normalizing fibromyalgia as a chronic illness

D. Clauw, Y. D'arcy, L. Pauer, 2018, Postgraduate medicine.

Association of Alterations in Gray Matter Volume With Reduced Evoked‐Pain Connectivity Following Short‐Term Administration of Pregabalin in Patients With Fibromyalgia

V. Napadow, D. Clauw, E. Ichesco, 2016, Arthritis & rheumatology.

Pregabalin Rectifies Aberrant Brain Chemistry, Connectivity, and Functional Response in Chronic Pain Patients

Richard E. Harris, V. Napadow, P. Sundgren, 2013, Anesthesiology.

MUSCULOSKELETAL SECTION Original Research Article Time to Improvement of Pain and Sleep Quality in Clinical Trials of Pregabalin for the Treatment of Fibromyalgia

L. Arnold, A. Clair, B. Emir, 2016 .